Fluid therapy in diabetic ketoacidosis

Abstract

Purpose of review To evaluate recent evidence (2021–2023) on fluid therapy in diabetic ketoacidosis. Key evidence gaps which require generation of new evidence are discussed. Recent findings Balanced crystalloid solutions, compared to the commonly recommended and used 0.9% sodium chloride solution (saline), may result in better outcomes for patients with diabetic ketoacidosis, including faster resolution of acidosis, less hyperchloremia and shorter hospital length of stay. Upcoming results from randomized trials may provide definitive evidence on the use of balanced crystalloid solutions in diabetic ketoacidosis. Evidence remains scarce or conflicting for the use of “two-bag” compared to conventional “one-bag” fluid, and rates of fluid administration, especially for adult patients. In children, concerns about cerebral oedema from faster fluid administration rates have not been demonstrated in cohort studies nor randomized trials. Summary Fluid therapy is a key aspect of diabetic ketoacidosis management, with important evidence gaps persisting for several aspects of management despite recent evidence.

Ketoacidosis and SGLT2 Inhibitors: A Narrative Review

“…Despite this, according to some recent results from randomized trials, the use of balanced crystalloid solutions, compared to the commonly used 0.9% sodium chloride solution, may provide better outcomes for DKA patients, resulting more quickly in a lower resolution of acidosis, lower hyperchloremia and shorter hospitalization [99].…”